IMC-11F8

BIOLOGICAL2 trials

Sponsors

Eli Lilly and Company

Conditions

NeoplasmsSolid Tumors

Phase 1

Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy

CompletedNCT00801177

Eli Lilly and CompanySolid Tumors

Start: 2004-11-30End: 2007-02-28Updated: 2010-10-13

Study of IMC-11F8 in Participants With Advanced Solid Tumors

CompletedNCT01088464

Eli Lilly and CompanyNeoplasms

Start: 2010-01-31End: 2012-02-29Updated: 2017-02-03